Evidence map›Paper›PMID 33919296›Full record

ArticleMicroorganisms2021

Fecal Microbiota Perspective for Evaluation of Prebiotic Potential of Bamboo Hemicellulose Hydrolysate in Mice: A Preliminary Study.

Nao Ikeyama, Mitsuo Sakamoto, Moriya Ohkuma, Shigeru Hiramoto, Jianpeng Wang, Shigenobu Tone, Kiwamu Shiiba

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nao IkeyamaRIKEN BioResource Research Center, Microbe Division/Japan Collection of Microorganisms, Tsukuba, Ibaraki 305-0074, Japan.
Mitsuo SakamotoRIKEN BioResource Research Center, Microbe Division/Japan Collection of Microorganisms, Tsukuba, Ibaraki 305-0074, Japan.ORCID 0000-0002-3622-4642
Moriya OhkumaRIKEN BioResource Research Center, Microbe Division/Japan Collection of Microorganisms, Tsukuba, Ibaraki 305-0074, Japan.
Shigeru HiramotoDivision of Life Science and Engineering, Tokyo Denki University, Ishisaka, Hatoyama, Saitama 350-0394, Japan.
Jianpeng WangDivision of Life Science and Engineering, Tokyo Denki University, Ishisaka, Hatoyama, Saitama 350-0394, Japan.
Shigenobu ToneDivision of Life Science and Engineering, Tokyo Denki University, Ishisaka, Hatoyama, Saitama 350-0394, Japan.
Kiwamu ShiibaDivision of Life Science and Engineering, Tokyo Denki University, Ishisaka, Hatoyama, Saitama 350-0394, Japan.ORCID 0000-0002-1776-6681
Tokyo Denki University · JPRIKEN BioResource Research Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bamboo hemicellulose hydrolysate (BHH) may possess antihypercholesterolemic activity; however, this activity requires further comprehensive study to assess the prebiotic mechanisms of BHH in vivo. Here, we used high-throughput 16S rRNA gene sequencing to preliminarily investigate the correlations between BHH and the fecal microbiomes of three groups of mice fed either a normal diet, a high-fat diet, or a high-fat diet supplemented with 5% BHH for 5 weeks. Alpha diversity (within community) was nonsignificant for all groups; however, beta diversity analysis among communities showed that 5% BHH suppressed the significant changes induced by the high-fat diet. The

Indexed as

bamboo hemicellulose hydrolysatesfecal microbial compositionfecal pHserum cholesterolshort-chain fatty acids (SCFAs)

Identifiers

PMID33919296
PMCPMC8143322
OpenAlexW3154823096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.